Exosome Diagnostics and Therapeutics: Global Markets

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Exosome Diagnostics and Therapeutics: Global Markets 2015-2021 - Market to Grow from $16.1 Million in 2016 to $111.8 million in 2021, a Five-Year CAGR of 47.3%

Dublin, Oct. 06, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Exosome Diagnostics and Therapeutics: Global Markets" report to their offering. "Exosome Diagnostics and Therapeutics: Global Markets" provides an overview of the current state of the exosome industry, existing products on the market and detailed analysis of the competitive environments, including new potential markets for novel products, diagnostics and therapeutics development. The study includes information about significant players in this field of study, trends and obstacles and other information affecting exosome market development.

This report provides: - An overview of the global markets and related technologies for exosome diagnostics and therapeutics. - Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021. - Breakdowns of new and exisiting diagnostic methods. - Evaluation of current therapeutics and those likely to be realized in the near future. - Analyses of the market's dynamics, specifically growth drivers, restraints, and opportunities. - Profiles of major players in the industry. Highlights: - The global market for exosome diagnostics and therapeutics is projected to grow from $16.1 million in 2016 to $111.8 million in 2021, a five-year compound annual growth rate (CAGR) of 47.3%. - Diagnostics is the largest sector of the market, expected to grow from $10.0 million in 2016 to $100.0 million in 2021 at a CAGR of 58.5% for the period. - Therapeutics is expected to grow from $5.0 million in 2016 to $10.0 million in 2021, a CAGR of 14.9%. Key Topics Covered: Chapter 1: Introduction - Study Goals And Objectives - Reasons For Doing This Study - Scope And Format - Methodology And Information Sources - Intended Audience - Analyst's Credentials Chapter 2: Summary Chapter 3: Introduction To Exosome Market Chapter 4: Exosome Diagnostics Market - Market Participants In Exosome-Based Diagnostics Sector - Evaluation Of Current Diagnostics Sector In Exosome Market Chapter 5: Exosome Therapeutics Market - Market Potential For Exosome Therapeutics - Market Participants In Exosome-Based Therapeutics Sector Chapter 6: Exosome Reagents And Research Tools Market - Market Participants For Reagents And Tools For Exosome Research - Evaluation Of Current Tools And Reagents Sector In Exosome Market Chapter 7: Patent Analysis Of Exosome Market Chapter 8: Impact Of Exosome Research On Specific Biopharmaceuticals Markets Chapter 9: Market Summary Chapter 10: Select Companies Overview - Aethlon Medical Inc. - Exosome Diagnostics Inc. - Nanosomix Inc. - System Biosciences (Sbi) - Thermo Fisher Scientific Inc. - Ymir Genomics Llc Chapter 11: List Of The Companies Mentioned In Report - 101Bio - Aegle Therapeutics - Aethlon Medical Inc. - Amarantus Bioscience Holdings Inc. - Amsbio LLC - Bioregenerative Sciences Inc. - Capricor Therapeutics - Caris Life Sciences - Cell Guidance Systems LLC - Ciloa - Codiak Biosciences - Dreirosen Pharma - Evomic Science LLC - Excytex - Exiqon, Inc - Exocyte Therapeutics Pte Ltd. - Exosome Diagnostics Inc. - Exosome Science - Exosomics Siena Spa - Exovita Biosciences - Hansabiomed - ITH, Immune Therapy Holdings AB - IZON Science - JSR Micro Inc. - Medistem/Intrexon Corp. - Miltenyi Biotec Gmbh - Nanosight/Malvern Instruments Ltd. - Nanosomix Inc. - New England Peptide Inc. - Norgen Biotek Corp - NX Pharmagen - Orion Pharma Ltd. - Panacea Pharmaceuticals - Paradigm Biopharmaceuticals - Particle Metrix Inc. - Pfizer - Promega Corp. - Qiagen - Redermis - Reneuron Group Plc - Sistemic - System Biosciences (SBI) - Therapeutics Solutions International - Thermofisher Scientific - YMIR Genomics LLC For more information about this report visit http://www.researchandmarkets.com/research/fmhx3n/exosome

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Diagnostics

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICAC's Landmark Program Strengthens Africa's Anti-Corruption Efforts

Updated Category News Views 2

A Bold Step Towards Integrity Corruption has long been a thorn in the side of progress for many regions, and watching the Hong Kong International Academy Against Corruption (HKIAAC) step up to the plate in Africa feels like a much-needed move. I mean, when you've got the collective wisdom of folks who've been through the wringer on these issues, you'd be wise to pay heed....

Continue Reading
MEDITECH and Lifemed AI Join Forces on Healthcare AI

Updated Category News Views 7

Lifemed AI and MEDITECH: A New Chapter in Healthcare You’d think by now the healthcare systems would be catching a break with technology, but here comes another twist. Lifemed AI and MEDITECH have banded together to tackle the notorious issue of claim denials head-on. Picture this: billions squandered every year because of avoidable administrative slip-ups. That's money...

Continue Reading
Network Brainiacs Expands Footprint into Maryland Market

Updated Category News Views 6

Network Brainiacs Steps into Maryland Territory If you're in the tech services game, expansion stories are the bread and butter of this business. Network Brainiacs, a seasoned veteran in the managed IT and cybersecurity sectors, has taken their first big step into Maryland by acquiring Computer Enhancement Systems (CES), a notable player in the field, as of September 1,...

Continue Reading
Hyliion Faces Legal Whirlwind After Stock Tumbles 19.3%

Updated Category News Views 8

Battered by Allegations: Hyliion in Legal Crosshairs Here's a hot mess Hyliion's found itself in. Amidst allegations of deception, the stock has dropped a hefty 19.3%. For anyone keeping tabs on this one, the legal eagles over at The Law Offices of Frank R. Cruz have swooped in, announcing a class action that's got all the trimmings of your classic securities mess. The...

Continue Reading
Shareholders Face Potential Unequal Deals Amid Big Mergers

Updated Category News Views 2

Are Shareholders Getting the Short End of the Stick? Ever feel like the small fish in a big corporate pond? That's the scene unfolding with EFSI, VCTR, and CSR shareholders wondering if they're getting a fair shake. The potential here smells like a fat payday for insiders, while ordinary investors might just be scraping for crumbs. Let's dig into this mess. Under the...

Continue Reading
Laredo Oil Eyes Big Gains in Argentina's Oil Play

Updated Category News Views 6

Argentina's Oil Play: Laredo Oil's Bold Venture Talk about shooting for the stars. Laredo Oil's second tête-à-tête with Santa Cruz Province's big wigs highlights their itch to rejuvenate Argentina's tired oil fields. For folks who know the nitty-gritty of oil, we're talking about the Golfo San Jorge Basin, a place where old dogs might learn new tricks thanks to that...

Continue Reading
AHN Opens Clinic for Severe Postpartum Tear Care

Updated Category News Views 6

A Game Changer for Postpartum Recovery When it comes to childbirth, you think you've heard it all, but here's a twist—Allegheny Health Network (AHN) just swung the doors open on a clinic laser-focused on a very raw deal: third- and fourth-degree perineal lacerations. We're diving into new territory where one network sees the gap and jumps into action, calling in the...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 9

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Volkswagen Leasing's MXN 2.5B Move Through Bolsa

Updated Category News Views 5

Reading the Fine Print in VW Leasing's Latest Move Let's get right into the weeds: Volkswagen Leasing's cranking out MXN 2.5 billion in long-term debt certificates. This maneuver ain't happening in a vacuum—it's powered by the intricate levers behind Greenberg Traurig's sharp legal mind. This isn't just another financial transaction; it's a strategically framed...

Continue Reading
XTI Aerospace Eyes Growth Amid Revenue Slip

Updated Category News Views 4

A Second Quarter Snapshot Ah, the world of aerospace—where soaring ambitions often face a reality check. XTI Aerospace, hitching a ride on the drone tech boom, found itself dealing with a mixed bag this past second quarter. Coming from the streets of Miami with its quarterly numbers, XTI's interim CEO Jeremy Schneiderman is banking on drones to lift their revenue skies....

Continue Reading

Top 5 Most Recently Viewed Articles

Cymbiotika Lands Again on Inc. 5000 List, Five-Year Streak

Updated Category News Views 12

Another Feather in Cymbiotika's Cap Alright, let me paint a picture for you: Cymbiotika is strutting down the runway of the annual Inc. 5000 list, holding its head high for the fifth year running. A steady march of glory in the dog-eat-dog world of private companies! Spotlight on Perseverance and Innovation Here's a wellness brand that seems to have cracked the code for...

Continue Reading
SportsMed Physical Therapy Expands Presence with New Clinic

Updated Category News Views 277

Expansion of SportsMed Physical Therapy SportsMed Physical Therapy is excited to announce the acquisition of a new clinic, enhancing its commitment to providing comprehensive rehabilitation and wellness services. This acquisition propels the total number of SportsMed clinics to 51, significantly improving patient access to high-quality care across New Jersey and...

Continue Reading
Exploring Breakthroughs in Space Tech: Rocket Lab and AST SpaceMobile

Updated Category News Views 638

Rocket Lab Achieves Milestones in Launch Technology Rocket Lab USA Inc. (NASDAQ: RKLB) recently celebrated a remarkable accomplishment with its 68th Electron launch, known as the "Symphony In The Stars" mission. This event is notable as it marks the second launch the company executed in less than 48 hours, showcasing their swift turnaround capabilities. Rapid Launch...

Continue Reading
Understanding Home Bancorp's Earnings Expectations and Trends

Updated Category News Views 133

Analyzing Home Bancorp's Earnings Potential Home Bancorp (NASDAQ: HBCP) is poised to disclose its quarterly earnings soon. Investors are keenly anticipating the report, hoping to see figures that not only meet but exceed market expectations. This eagerness stems from a history of previous earnings releases that provided valuable insights into the company's operational...

Continue Reading
Sun Life Financial's Strategic Leadership Transition Underway

Updated Category News Views 455

Sun Life Financial Announces Key Leadership Change Sun Life Financial Inc. (TSX: SLF) is thrilled to share that Brennan Kennedy has been appointed as the new Senior Vice-President and Chief Actuary. This decision marks a significant advancement for both Brennan and the organization. He will officially step into this pivotal role shortly, succeeding Kevin Morrissey, who is...

Continue Reading